Cargando…

Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease

Inflammation has long been known to play a role in atherogenesis and plaque complication, as well as in some drugs used in therapy for atherosclerotic disease, such as statins, acetylsalicylic acid, and modulators of the renin-angiotensin system, which also have anti-inflammatory effects. Furthermor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pello Lázaro, Ana María, Blanco-Colio, Luis M., Franco Peláez, Juan Antonio, Tuñón, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268779/ https://www.ncbi.nlm.nih.gov/pubmed/34198968 http://dx.doi.org/10.3390/jcm10132835

Ejemplares similares

Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2020)

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease
por: Martín-Reyes, Roberto, et al.
Publicado: (2016)

Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2017)

Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes
por: López‐Castillo, Marta, et al.
Publicado: (2020)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease
por: Tuñón, José, et al.
Publicado: (2015)

Potential Anti-Inflammatory Treatment of Ischemic Heart Disease
por: Hodzic, Enisa
Publicado: (2018)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021)

Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions
por: Kallmeyer, Andrea, et al.
Publicado: (2023)

MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
por: Blanco-Colio, Luis M., et al.
Publicado: (2021)

Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study
por: Devesa, Ana, et al.
Publicado: (2022)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

Statin use is associated with reduced mortality after respiratory viral infection
por: Franco-Peláez, Juan Antonio, et al.
Publicado: (2021)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
por: Martínez-Milla, Juan, et al.
Publicado: (2022)

Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
por: Lumpuy-Castillo, Jairo, et al.
Publicado: (2020)

Atherosclerosis and Other Related-Arterial Diseases
por: Blanco-Colio, Luis M., et al.
Publicado: (2023)

Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
por: Lorenzo-Almorós, Ana, et al.
Publicado: (2020)

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
por: Tuñón, José, et al.
Publicado: (2021)

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients
por: Gutiérrez‐Landaluce, Carlos, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Actions of Polyphenols from Red and White Grape Pomace in Ischemic Heart Diseases
por: Bocsan, Ioana Corina, et al.
Publicado: (2022)

Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases
por: Martin-Ventura, Jose Luis, et al.
Publicado: (2022)

Beta-blocker therapy in elderly patients with renal dysfunction and heart failure
por: Martínez-Milla, Juan, et al.
Publicado: (2021)

Union is strength: antiviral and anti-inflammatory drugs for COVID-19
por: Naveja, Jose J., et al.
Publicado: (2021)

Ischemic Time as a Predictor of Physical Recovery in the First Months after Heart Transplantation
por: Buendía-Fuentes, Francisco, et al.
Publicado: (2012)

Designing Single-Molecule Magnets as Drugs with Dual Anti-Inflammatory and Anti-Diabetic Effects
por: Navas, Arturo, et al.
Publicado: (2020)

Ivabradine: An Intelligent Drug for the Treatment of Ischemic Heart Disease
por: Riccioni, Graziano
Publicado: (2012)

Stromal Vascular Fraction Transplantation as an Alternative Therapy for Ischemic Heart Failure: Anti-inflammatory Role
por: Premaratne, Goditha U, et al.
Publicado: (2011)

Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
por: Wu, Shu‐Jie, et al.
Publicado: (2017)

The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study
por: Venegas‐Rodríguez, Ana, et al.
Publicado: (2023)

Macrophage Polarization, Metabolic Reprogramming, and Inflammatory Effects in Ischemic Heart Disease
por: Sun, Xiaoqian, et al.
Publicado: (2022)

Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease
por: Fan, Chengming, et al.
Publicado: (2020)

Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease
por: Messadi, Erij
Publicado: (2023)

Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
por: Mazidi, Mohsen, et al.
Publicado: (2023)

Neuroinflammation and anti-inflammatory therapy for ischemic stroke
por: Cao, Yangyue, et al.
Publicado: (2023)

Oxidative Stress in Ischemic Heart Disease
por: Kibel, Aleksandar, et al.
Publicado: (2020)

Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention
por: Jucan, Alina Ecaterina, et al.
Publicado: (2022)

Annexins and cardiovascular diseases: Beyond membrane trafficking and repair
por: Méndez-Barbero, Nerea, et al.
Publicado: (2022)

Effect of Dementia on the Use of Drugs for Secondary Prevention of Ischemic Heart Disease
por: Fowler, Nicole R., et al.
Publicado: (2014)

IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2019)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_429tfc5b6ift4krc4blil9shrp